aldafermin
Recombinant proteinexperimental
Clinical trial activity
14 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
9
Phase 3
1
Phase 4
0
Earliest trial started Jan 1, 2013 (NCT01776528)
Timeline
Indications
Studied for
- Bile Acids and Salts · Phase 2
- Cholangitis, Sclerosing · Phase 2/Phase 3
- Constipation · Phase 1/Phase 2
- Diabetes Mellitus · Phase 2
- Diarrhea · Phase 2
- Healthy Volunteers · Phase 1
- Irritable Bowel Syndrome · Phase 2
- Kidney Diseases · Phase 1
- Liver Cirrhosis · Phase 2
- Liver Cirrhosis, Biliary · Phase 2
- Liver Diseases · Phase 1
- Non-alcoholic Fatty Liver Disease · Phase 2
Mechanism of action
- FGFR4-KLBACTIVATOR
FGFR4-KLB activator
- FGF1/KLBACTIVATOR
FGF1/KLB activator
- Fibroblast growth factor 19Supplementation
FGF19 supplementation
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4298055 ↗
Also known as
- ngm282
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06654726 | Phase 2/Phase 3 (Phase 3) | Oct 21, 2024 | NGM Biopharmaceuticals, Inc |
| NCT05130047 | Phase 2 | Nov 30, 2021 | Mayo Clinic, NGM Biopharmaceuticals, Inc |
| NCT04828265 | Phase 1 | Apr 1, 2021 | NGM Biopharmaceuticals, Inc |
| NCT04823702 | Phase 1 | Apr 1, 2021 | NGM Biopharmaceuticals, Inc |
| NCT04210245 | Phase 2 | Dec 31, 2019 | NGM Biopharmaceuticals, Inc |
| NCT04179630 | Phase 1 | Nov 8, 2019 | NGM Biopharmaceuticals, Inc |
| NCT03912532 | Phase 2 | Apr 1, 2019 | NGM Biopharmaceuticals, Inc |
| NCT02704364 | Phase 2 | Feb 1, 2016 | NGM Biopharmaceuticals, Inc |
| NCT02649062 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2015 | NGM Biopharmaceuticals, Inc |
| NCT02443116 | Phase 2 | May 1, 2015 | NGM Biopharmaceuticals, Inc |
| NCT02135536 | Phase 2 | May 1, 2014 | NGM Biopharmaceuticals, Inc |
| NCT02026401 | Phase 2 | Feb 1, 2014 | NGM Biopharmaceuticals, Inc |
| NCT01943045 | Phase 2 | Sep 1, 2013 | NGM Biopharmaceuticals, Inc |
| NCT01776528 | Phase 1 | Jan 1, 2013 | NGM Biopharmaceuticals, Inc |
Showing 14 of 14 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NGM Biopharmaceuticals, Inc | For profit | 14 | 13 | 3 | 2013 |
| Mayo Clinic | Academic/Hospital | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1